Coda Biotherapeutics

0 followers


CODA Biotherapeutics’ revolutionary chemogenetic platform aims to control the activity of cells to treat disease.

Industries

Employees

11-50

Links

Org chart

Michael Narachi
President & CEO

Michael Narachi

Collapse
Susan Catalano
Chief Scientific Officer
Annahita Keravala
SVP, Gene Therapy & Translation
Steven Dodson
SVP, Development & Pharmacology